Frontline Lenalidomide for AL Amyloidosis Involving Myocardium
Clinical trial NCT04298372 · COMPLETED
Trial details
- NCT number
- NCT04298372
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-20
- Primary completion
- 2021-11-25
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.